https://www.indianpharmapost.com/zydus-wellness-acquires-uk-based-comfort-click-for-rs-2846-cr-176922025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/gc-biopharma-submits-ind-to-begin-phase-3-clinical-trial-for-barycela-in-thailand-177002025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-suspends-valnevas-license-of-chikungunya-vaccine-ixchiq-in-us-176992025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisks-wegovy-cuts-risk-of-heart-attack-stroke-or-death-by-57-compared-to-tirzepatide-176982025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/apitoria-pharma-receives-5-observations-from-usfda-for-api-facility-176972025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-taps-replicate-biosciences-srrna-platform-for-obesity-176962025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/roche-alnylam-to-initiate-phase-3-cardiovascular-outcomes-trial-of-zilebesiran-176952025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-presents-phase-iii-victor-clinical-trial-data-of-vericiguat-at-esc-congress-2025-176942025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/gea-jgc-commission-new-spray-dryer-at-chugai-pharmaceutical-in-japan-176932025-08-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-approves-novavaxs-nuvaxovid-2025-2026-formula-for-prevention-of-covid-19-177012025-08-31T00:00:00+05:30always0.9